Krsnaa Diagnostics Gets In-Principle Approval for Warrant Issue

Krsnaa Diagnostics Ltd has received in-principle approval from BSE Limited and National Stock Exchange of India Limited for the issuance of 16,21,000 convertible warrants to its Promoter and Promoter Group. These warrants are convertible into equity shares at an issue price of Rs. 566/- each. The approval is subject to the company fulfilling several conditions, including filing listing applications, obtaining statutory approvals, and strengthening internal controls to monitor trades by allottees. The company is advised to obtain undertakings from allottees regarding no intra-day trading until the allotment date.